A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thyroid hormone stimulus.
3 statements, 0 sitelinks - 20:55, 28 May 2023
A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thyroid hormone stimulus.
4 statements, 0 sitelinks - 21:09, 28 May 2023
Catalysis of the reaction: 2-oxoglutarate + 3,5,3'-triiodo-L-thyronine = 3,5,3'-triiodothyropyruvate + L-glutamate.
1 statement, 0 sitelinks - 21:17, 28 May 2023
thyroid hormone
7 statements, 0 sitelinks - 21:13, 28 May 2023
...lucagon-like peptide-1 receptor/ja|グルカゴン様ペプチド-1（GLP-1）受容体]]を含む複数の[[peptide hormone/ja|ペプチドホルモン]]受容体を活性化する薬物の一種である。これらの薬物は[[GLP-1 receptor agonist/ja|GLP-1受容体作
[[estrogen/ja|エストロゲン]]、[[thyroid hormone/ja|甲状腺ホルモン]]（T3）、[[dexamethasone/ja|デキサメタゾン]]などの他のホルモンをGLP-1やグルカゴンに結合させると、結
...
5 KB (157 words) - 07:13, 3 April 2024
...right.) '''1.''' [[Pineal gland]] '''2.''' [[Pituitary gland]] '''3.''' [[Thyroid gland]] '''4.''' [[Thymus]] '''5.''' [[Adrenal gland]] '''6.''' [[Pancreas]
# Endocrine gland hypofunction/hypo[[secretion]] (leading to hormone deficiency)
...
7 KB (691 words) - 11:10, 16 February 2024
...right.) '''1.''' [[Pineal gland]] '''2.''' [[Pituitary gland]] '''3.''' [[Thyroid gland]] '''4.''' [[Thymus]] '''5.''' [[Adrenal gland]] '''6.''' [[Pancreas]
# Endocrine gland hypofunction/hypo[[secretion]] (leading to hormone deficiency)
...
7 KB (737 words) - 13:22, 17 February 2024
...''' [[Pineal gland/ja|松果体]] '''2.''' [[Pituitary gland/ja|下垂体]] '''3.''' [[Thyroid gland/ja|甲状腺]] '''4.''' [[Thymus/ja|胸腺]] '''5.''' [[Adrenal gland/ja|副腎]] '
...ism/ja|甲状腺機能亢進症]]は、[[thyroid hormone/ja|甲状腺ホルモン]]の過剰と[[thyroid stimulating hormone/ja|甲状腺刺激ホルモン]]の低レベルを伴う。
...
9 KB (484 words) - 18:09, 16 February 2024
| diseases = [[Diabetes/ja]], [[Thyroid disease/ja]], [[Androgen excess/ja]]
| tests = [[Thyroid function tests/ja]], [[Blood sugar level/ja]]
...
22 KB (746 words) - 20:58, 20 February 2024
...-agonist peptides''' are a class of drugs that activate multiple [[peptide hormone]] receptors including the [[glucagon-like peptide-1 receptor|glucagon-like
Glucagon is a hormone that generally opposes the action of [[insulin]]. It increases blood glucos
...
3 KB (451 words) - 22:02, 2 April 2024
...-agonist peptides''' are a class of drugs that activate multiple [[peptide hormone]] receptors including the [[glucagon-like peptide-1 receptor|glucagon-like
Glucagon is a hormone that generally opposes the action of [[insulin]]. It increases blood glucos
...
3 KB (471 words) - 22:01, 2 April 2024
...docrine system'''）は、[[gland/ja|腺]]から直接[[circulatory system/ja|循環系]]に放出される[[hormone/ja|ホルモン]]のフィードバックループからなる[[organism/ja|生物]]のメッセンジャーシステムであり、遠くの臓器を標的として調節する。[
[[humans/ja|ヒト]]では、主要な[[endocrine gland/ja|内分泌腺]]は[[thyroid gland/ja|甲状腺]]、[[parathyroid gland/ja|副甲状腺]]、[[pituitary gland/ja/ja|下垂体]]、
...
34 KB (989 words) - 16:52, 13 April 2024
...one/ja|甲状腺ホルモン]]もエネルギー消費量を上昇させたが、心臓へのリスクやその他の副作用のために減量には使われなくなった。[[thyroid hormone receptor beta/ja|甲状腺ホルモン受容体β]]に作用する選択的[[thyromimetic/ja|サイロミメティック]]製剤は、甲状腺ホ
...0年代から1930年代にかけてのことである。[[hypothyroidism/ja|甲状腺機能低下症]]に対する有効性に基づいて、[[thyroid hormone/ja|甲状腺ホルモン]]は[[hyperthyroidism/ja|甲状腺機能低下症]]の人々の肥満に対する人気のある治療法となった。効果はそれなりに
...
22 KB (659 words) - 09:48, 8 March 2024
| diseases = [[Diabetes]], [[Thyroid disease]], [[Androgen excess]]
| tests = [[Thyroid function tests]], [[Blood sugar level]]s
...
17 KB (2,368 words) - 13:43, 20 February 2024
| diseases = [[Diabetes]], [[Thyroid disease]], [[Androgen excess]]
| tests = [[Thyroid function tests]], [[Blood sugar level]]s
...
18 KB (2,440 words) - 13:43, 20 February 2024
{{Short description|Hormone-producing glands of a body}}
...'' is a messenger system in an [[organism]] comprising feedback loops of [[hormone]]s that are released by internal [[gland]]s directly into the [[circulatory
...
30 KB (4,228 words) - 20:42, 17 January 2024
{{Short description|Hormone-producing glands of a body}}
...'' is a messenger system in an [[organism]] comprising feedback loops of [[hormone]]s that are released by internal [[gland]]s directly into the [[circulatory
...
30 KB (4,330 words) - 20:41, 17 January 2024
...a]] may be able to exert some of the beneficial [[thermogenic]] effects of thyroid hormones with fewer adverse effects, but none have received approval as of
...an to appear. Based on its effectiveness for [[hypothyroidism]], [[thyroid hormone]] became a popular treatment for obesity in [[euthyroid]] people. It had a
...
17 KB (2,406 words) - 18:16, 7 March 2024
...a]] may be able to exert some of the beneficial [[thermogenic]] effects of thyroid hormones with fewer adverse effects, but none have received approval as of
...an to appear. Based on its effectiveness for [[hypothyroidism]], [[thyroid hormone]] became a popular treatment for obesity in [[euthyroid]] people. It had a
...
18 KB (2,460 words) - 18:15, 7 March 2024
...ed to an Fc fragment of human IgG4. [[glucagon-like peptide-1|GLP-1]] is a hormone that is involved in the normalization of level of glucose in blood (glycemi
...fonylurea]]s or [[insulin]]. There is also a potential risk of [[medullary thyroid carcinoma]] associated with the use of the drug.
...
9 KB (1,155 words) - 10:30, 12 February 2024